Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF7
|
ENSG00000081059.15 | transcription factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_133449822_133450240 | TCF7 | 371 | 0.890686 | -0.76 | 1.8e-02 | Click! |
chr5_133449554_133449795 | TCF7 | 728 | 0.719481 | -0.62 | 7.4e-02 | Click! |
chr5_133480587_133480738 | TCF7 | 2179 | 0.316375 | -0.58 | 1.0e-01 | Click! |
chr5_133467046_133467197 | TCF7 | 7812 | 0.214339 | -0.48 | 1.9e-01 | Click! |
chr5_133481113_133481264 | TCF7 | 2705 | 0.276763 | -0.48 | 1.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_78398482_78399243 | 1.16 |
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
1534 |
0.56 |
chr4_157890038_157890662 | 1.10 |
PDGFC |
platelet derived growth factor C |
1705 |
0.41 |
chr7_143579344_143579634 | 0.88 |
FAM115A |
family with sequence similarity 115, member A |
487 |
0.8 |
chr6_121759244_121759464 | 0.78 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
2516 |
0.27 |
chr9_21558481_21558945 | 0.77 |
MIR31HG |
MIR31 host gene (non-protein coding) |
955 |
0.56 |
chr10_29824157_29824642 | 0.76 |
ENSG00000207612 |
. |
9627 |
0.19 |
chr4_113739356_113739869 | 0.74 |
ANK2 |
ankyrin 2, neuronal |
347 |
0.9 |
chr5_39423074_39423254 | 0.68 |
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
1806 |
0.48 |
chr15_63335356_63335840 | 0.67 |
TPM1 |
tropomyosin 1 (alpha) |
377 |
0.85 |
chr13_100309968_100311087 | 0.66 |
ENSG00000263615 |
. |
15214 |
0.18 |
chr2_157657104_157657488 | 0.65 |
ENSG00000263848 |
. |
214473 |
0.02 |
chr4_140926197_140926348 | 0.64 |
MAML3 |
mastermind-like 3 (Drosophila) |
114151 |
0.06 |
chr12_15475849_15476234 | 0.64 |
PTPRO |
protein tyrosine phosphatase, receptor type, O |
554 |
0.83 |
chr10_114886062_114886413 | 0.63 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
17442 |
0.28 |
chr2_218807657_218808117 | 0.63 |
TNS1 |
tensin 1 |
906 |
0.64 |
chr5_146835005_146835156 | 0.63 |
DPYSL3 |
dihydropyrimidinase-like 3 |
1251 |
0.58 |
chr17_31255277_31255844 | 0.63 |
TMEM98 |
transmembrane protein 98 |
332 |
0.89 |
chr1_162602563_162603214 | 0.63 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
628 |
0.74 |
chr7_113722711_113723554 | 0.62 |
FOXP2 |
forkhead box P2 |
3483 |
0.3 |
chr2_240362447_240362854 | 0.62 |
AC062017.1 |
Uncharacterized protein |
39151 |
0.15 |
chr15_42749089_42749416 | 0.62 |
ZNF106 |
zinc finger protein 106 |
459 |
0.78 |
chr5_92334165_92334384 | 0.62 |
ENSG00000221810 |
. |
281054 |
0.01 |
chr2_74780571_74780754 | 0.61 |
LOXL3 |
lysyl oxidase-like 3 |
400 |
0.5 |
chr6_122931066_122932065 | 0.61 |
PKIB |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
188 |
0.97 |
chr14_70059777_70059928 | 0.60 |
KIAA0247 |
KIAA0247 |
18461 |
0.2 |
chr7_134465455_134465673 | 0.60 |
CALD1 |
caldesmon 1 |
1135 |
0.64 |
chr1_150254993_150255622 | 0.60 |
C1orf51 |
chromosome 1 open reading frame 51 |
78 |
0.94 |
chr4_169753076_169754370 | 0.58 |
RP11-635L1.3 |
|
365 |
0.61 |
chr3_24562978_24563646 | 0.58 |
ENSG00000265028 |
. |
386 |
0.87 |
chr14_53414752_53414935 | 0.58 |
FERMT2 |
fermitin family member 2 |
2443 |
0.38 |
chrX_103381032_103381192 | 0.58 |
SLC25A53 |
solute carrier family 25, member 53 |
20596 |
0.16 |
chr18_52919364_52919515 | 0.57 |
TCF4 |
transcription factor 4 |
23463 |
0.25 |
chr9_18476160_18476529 | 0.57 |
ADAMTSL1 |
ADAMTS-like 1 |
2113 |
0.45 |
chr1_216705124_216705304 | 0.57 |
USH2A |
Usher syndrome 2A (autosomal recessive, mild) |
108476 |
0.08 |
chr14_29228686_29229081 | 0.56 |
RP11-966I7.1 |
|
5586 |
0.17 |
chr8_131960988_131961496 | 0.56 |
RP11-737F9.1 |
|
13587 |
0.24 |
chr8_119024148_119024424 | 0.56 |
EXT1 |
exostosin glycosyltransferase 1 |
98367 |
0.09 |
chr9_109622995_109623671 | 0.55 |
ZNF462 |
zinc finger protein 462 |
2045 |
0.37 |
chr14_53418107_53419061 | 0.55 |
FERMT2 |
fermitin family member 2 |
569 |
0.83 |
chr3_112356424_112356629 | 0.55 |
CCDC80 |
coiled-coil domain containing 80 |
418 |
0.88 |
chr13_110958781_110959436 | 0.55 |
COL4A1 |
collagen, type IV, alpha 1 |
370 |
0.6 |
chr21_17960305_17960805 | 0.54 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr11_89223927_89224152 | 0.54 |
NOX4 |
NADPH oxidase 4 |
107 |
0.98 |
chr14_52120265_52120462 | 0.54 |
FRMD6 |
FERM domain containing 6 |
1665 |
0.39 |
chr15_86163319_86163521 | 0.54 |
RP11-815J21.3 |
|
7500 |
0.15 |
chr7_94027821_94027972 | 0.54 |
COL1A2 |
collagen, type I, alpha 2 |
4023 |
0.33 |
chr9_18474095_18474958 | 0.54 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr2_12859088_12859514 | 0.53 |
TRIB2 |
tribbles pseudokinase 2 |
937 |
0.67 |
chr3_52566781_52567334 | 0.53 |
NT5DC2 |
5'-nucleotidase domain containing 2 |
490 |
0.67 |
chr2_172970805_172971712 | 0.53 |
DLX2 |
distal-less homeobox 2 |
3630 |
0.25 |
chr2_236403954_236404487 | 0.53 |
AGAP1 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
1469 |
0.47 |
chr10_93073745_93074042 | 0.53 |
PCGF5 |
polycomb group ring finger 5 |
93348 |
0.09 |
chr16_73082076_73082698 | 0.53 |
ZFHX3 |
zinc finger homeobox 3 |
113 |
0.97 |
chr4_71587677_71588145 | 0.52 |
RUFY3 |
RUN and FYVE domain containing 3 |
183 |
0.92 |
chr15_48469342_48470564 | 0.52 |
MYEF2 |
myelin expression factor 2 |
597 |
0.66 |
chrX_139847263_139847516 | 0.52 |
CDR1 |
cerebellar degeneration-related protein 1, 34kDa |
19334 |
0.22 |
chr4_171010363_171010619 | 0.52 |
AADAT |
aminoadipate aminotransferase |
54 |
0.98 |
chr12_68375532_68375735 | 0.52 |
IFNG-AS1 |
IFNG antisense RNA 1 |
7592 |
0.32 |
chr6_28175291_28175856 | 0.51 |
ZSCAN9 |
zinc finger and SCAN domain containing 9 |
17091 |
0.12 |
chr1_67001631_67001824 | 0.51 |
SGIP1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
1762 |
0.47 |
chr10_14051355_14052213 | 0.51 |
FRMD4A |
FERM domain containing 4A |
1252 |
0.51 |
chr5_86264086_86264257 | 0.51 |
ENSG00000251951 |
. |
134492 |
0.05 |
chr5_158438402_158438767 | 0.50 |
CTD-2363C16.2 |
|
25770 |
0.2 |
chr9_22237663_22237957 | 0.50 |
CDKN2B-AS1 |
CDKN2B antisense RNA 1 |
124133 |
0.06 |
chr6_21310055_21310473 | 0.50 |
SOX4 |
SRY (sex determining region Y)-box 4 |
283708 |
0.01 |
chr6_44509899_44510345 | 0.50 |
ENSG00000266619 |
. |
106744 |
0.06 |
chr2_192111060_192111278 | 0.49 |
MYO1B |
myosin IB |
160 |
0.97 |
chr15_49915904_49916094 | 0.49 |
DTWD1 |
DTW domain containing 1 |
2703 |
0.26 |
chr4_16900069_16900243 | 0.49 |
LDB2 |
LIM domain binding 2 |
29 |
0.99 |
chr3_112356800_112357010 | 0.49 |
CCDC80 |
coiled-coil domain containing 80 |
39 |
0.98 |
chr8_20160380_20160531 | 0.49 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
1019 |
0.58 |
chr2_102051443_102051701 | 0.49 |
RFX8 |
RFX family member 8, lacking RFX DNA binding domain |
39165 |
0.16 |
chr10_104536012_104536214 | 0.49 |
WBP1L |
WW domain binding protein 1-like |
107 |
0.96 |
chr6_144066858_144067012 | 0.49 |
PHACTR2 |
phosphatase and actin regulator 2 |
67730 |
0.11 |
chr12_16759518_16759794 | 0.48 |
LMO3 |
LIM domain only 3 (rhombotin-like 2) |
78 |
0.98 |
chr2_24677199_24677463 | 0.48 |
NCOA1 |
nuclear receptor coactivator 1 |
37470 |
0.18 |
chr15_48936731_48936882 | 0.48 |
FBN1 |
fibrillin 1 |
1112 |
0.63 |
chr6_35396049_35396299 | 0.48 |
FANCE |
Fanconi anemia, complementation group E |
23964 |
0.16 |
chr19_39466084_39466309 | 0.48 |
FBXO17 |
F-box protein 17 |
354 |
0.78 |
chr13_110961306_110961457 | 0.47 |
COL4A2 |
collagen, type IV, alpha 2 |
1767 |
0.33 |
chr6_116219645_116219796 | 0.47 |
FRK |
fyn-related kinase |
104215 |
0.08 |
chr5_71404775_71404998 | 0.47 |
MAP1B |
microtubule-associated protein 1B |
1573 |
0.51 |
chr17_79476358_79476512 | 0.47 |
ENSG00000266077 |
. |
1700 |
0.19 |
chr4_20255917_20256182 | 0.47 |
SLIT2 |
slit homolog 2 (Drosophila) |
494 |
0.89 |
chr3_36421358_36421509 | 0.47 |
STAC |
SH3 and cysteine rich domain |
403 |
0.92 |
chr20_4953796_4953984 | 0.47 |
SLC23A2 |
solute carrier family 23 (ascorbic acid transporter), member 2 |
28255 |
0.16 |
chr18_25692719_25692870 | 0.47 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
15601 |
0.31 |
chr4_46392579_46392730 | 0.46 |
GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
233 |
0.66 |
chr18_32291325_32291476 | 0.46 |
DTNA |
dystrobrevin, alpha |
1139 |
0.62 |
chr16_87616023_87616343 | 0.46 |
RP11-482M8.3 |
|
19613 |
0.17 |
chr12_116962704_116963010 | 0.46 |
MAP1LC3B2 |
microtubule-associated protein 1 light chain 3 beta 2 |
34329 |
0.21 |
chr9_16704056_16704545 | 0.46 |
BNC2 |
basonuclin 2 |
780 |
0.71 |
chr13_24144563_24144801 | 0.46 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
121 |
0.98 |
chr5_172306134_172306575 | 0.46 |
ERGIC1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
25866 |
0.16 |
chr5_54864914_54865117 | 0.46 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
34137 |
0.18 |
chr5_176793939_176794146 | 0.46 |
RGS14 |
regulator of G-protein signaling 14 |
98 |
0.93 |
chr10_77157105_77157688 | 0.46 |
ENSG00000237149 |
. |
3881 |
0.22 |
chr5_140857632_140858335 | 0.45 |
ENSG00000242020 |
. |
900 |
0.34 |
chr16_73177494_73177661 | 0.45 |
C16orf47 |
chromosome 16 open reading frame 47 |
769 |
0.76 |
chr5_52098224_52098443 | 0.45 |
CTD-2288O8.1 |
|
14473 |
0.19 |
chr15_40630709_40631123 | 0.45 |
C15orf52 |
chromosome 15 open reading frame 52 |
582 |
0.52 |
chr8_38067542_38067777 | 0.45 |
BAG4 |
BCL2-associated athanogene 4 |
2548 |
0.18 |
chr2_109935421_109935606 | 0.45 |
ENSG00000265965 |
. |
5432 |
0.33 |
chr7_135771405_135771575 | 0.45 |
ENSG00000206705 |
. |
43339 |
0.17 |
chr5_151060368_151060611 | 0.45 |
CTB-113P19.1 |
|
3955 |
0.17 |
chr10_44879482_44879722 | 0.45 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
889 |
0.65 |
chr3_145968965_145969195 | 0.44 |
PLSCR4 |
phospholipid scramblase 4 |
114 |
0.98 |
chr7_92324656_92325109 | 0.44 |
ENSG00000206763 |
. |
6246 |
0.27 |
chr19_17190494_17190781 | 0.44 |
MYO9B |
myosin IXB |
4041 |
0.14 |
chrX_102940107_102940387 | 0.44 |
MORF4L2 |
mortality factor 4 like 2 |
902 |
0.43 |
chr8_16689434_16690090 | 0.44 |
ENSG00000264092 |
. |
31243 |
0.24 |
chr3_36805918_36806229 | 0.44 |
DCLK3 |
doublecortin-like kinase 3 |
24721 |
0.22 |
chr6_149745168_149745416 | 0.44 |
SUMO4 |
small ubiquitin-like modifier 4 |
23797 |
0.15 |
chr18_5895769_5896060 | 0.44 |
TMEM200C |
transmembrane protein 200C |
40 |
0.98 |
chr13_108520858_108521069 | 0.44 |
FAM155A |
family with sequence similarity 155, member A |
1880 |
0.44 |
chr5_146111978_146112129 | 0.44 |
ENSG00000265875 |
. |
2345 |
0.39 |
chr6_78172796_78173983 | 0.43 |
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
101 |
0.99 |
chr21_30594172_30594323 | 0.43 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
27779 |
0.12 |
chr2_119602332_119602483 | 0.43 |
EN1 |
engrailed homeobox 1 |
2847 |
0.38 |
chr11_46670801_46671004 | 0.43 |
ATG13 |
autophagy related 13 |
10070 |
0.15 |
chr5_33891538_33892159 | 0.43 |
ADAMTS12 |
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
198 |
0.94 |
chr1_170633420_170634117 | 0.43 |
PRRX1 |
paired related homeobox 1 |
690 |
0.8 |
chr9_16267382_16267618 | 0.43 |
C9orf92 |
chromosome 9 open reading frame 92 |
8811 |
0.32 |
chr1_98514169_98514606 | 0.43 |
ENSG00000225206 |
. |
2660 |
0.42 |
chr17_58821066_58821723 | 0.43 |
ENSG00000252534 |
. |
5013 |
0.22 |
chr15_96886136_96886425 | 0.43 |
ENSG00000222651 |
. |
9790 |
0.16 |
chr2_238318512_238318719 | 0.43 |
COL6A3 |
collagen, type VI, alpha 3 |
4176 |
0.24 |
chr10_63815746_63815944 | 0.43 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
6875 |
0.28 |
chr16_65152808_65153250 | 0.43 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
2804 |
0.44 |
chr9_130639317_130639975 | 0.43 |
AK1 |
adenylate kinase 1 |
376 |
0.71 |
chr4_158143735_158144020 | 0.42 |
GRIA2 |
glutamate receptor, ionotropic, AMPA 2 |
1059 |
0.6 |
chr2_219646650_219647418 | 0.42 |
CYP27A1 |
cytochrome P450, family 27, subfamily A, polypeptide 1 |
555 |
0.7 |
chr14_100260565_100260825 | 0.42 |
EML1 |
echinoderm microtubule associated protein like 1 |
923 |
0.67 |
chr16_2077067_2078193 | 0.42 |
SLC9A3R2 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
701 |
0.35 |
chr8_32441619_32441833 | 0.42 |
NRG1 |
neuregulin 1 |
21440 |
0.28 |
chr6_28641788_28642196 | 0.42 |
ENSG00000272278 |
. |
25950 |
0.18 |
chr13_33684806_33685110 | 0.42 |
STARD13-IT1 |
STARD13 intronic transcript 1 (non-protein coding) |
53588 |
0.13 |
chr13_31481253_31481536 | 0.42 |
MEDAG |
mesenteric estrogen-dependent adipogenesis |
551 |
0.78 |
chr7_93551338_93552000 | 0.42 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
658 |
0.67 |
chr6_132269338_132269679 | 0.42 |
RP11-69I8.3 |
|
2578 |
0.29 |
chr1_7439604_7439992 | 0.42 |
RP3-453P22.2 |
|
9681 |
0.21 |
chr10_104512266_104512417 | 0.42 |
WBP1L |
WW domain binding protein 1-like |
8614 |
0.15 |
chr8_42409749_42409900 | 0.42 |
SMIM19 |
small integral membrane protein 19 |
8253 |
0.18 |
chr13_96294255_96294727 | 0.41 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
1026 |
0.59 |
chr5_981171_981392 | 0.41 |
RP11-661C8.3 |
Uncharacterized protein |
1801 |
0.27 |
chr21_17566581_17566826 | 0.41 |
ENSG00000201025 |
. |
90386 |
0.1 |
chr11_40315226_40315699 | 0.41 |
LRRC4C |
leucine rich repeat containing 4C |
202 |
0.97 |
chr19_5292538_5292834 | 0.41 |
PTPRS |
protein tyrosine phosphatase, receptor type, S |
112 |
0.98 |
chr2_178498869_178499062 | 0.41 |
TTC30A |
tetratricopeptide repeat domain 30A |
15271 |
0.18 |
chr3_33318777_33319866 | 0.41 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr15_99978934_99979109 | 0.41 |
RP11-20G13.2 |
|
37501 |
0.14 |
chr19_1566819_1567637 | 0.41 |
MEX3D |
mex-3 RNA binding family member D |
301 |
0.76 |
chr2_238536720_238536977 | 0.41 |
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
629 |
0.71 |
chr15_43809516_43809667 | 0.41 |
MAP1A |
microtubule-associated protein 1A |
215 |
0.91 |
chr14_54418430_54418581 | 0.41 |
BMP4 |
bone morphogenetic protein 4 |
93 |
0.98 |
chr9_113530116_113530340 | 0.41 |
MUSK |
muscle, skeletal, receptor tyrosine kinase |
7399 |
0.3 |
chr4_86700210_86700446 | 0.41 |
ARHGAP24 |
Rho GTPase activating protein 24 |
469 |
0.88 |
chrX_69674453_69675874 | 0.41 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chrX_10851859_10852068 | 0.41 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
190 |
0.97 |
chr16_69200573_69200724 | 0.41 |
ENSG00000207083 |
. |
9032 |
0.12 |
chr18_21298054_21298210 | 0.40 |
LAMA3 |
laminin, alpha 3 |
28484 |
0.19 |
chrX_99890951_99891409 | 0.40 |
TSPAN6 |
tetraspanin 6 |
623 |
0.71 |
chr16_4069301_4069467 | 0.40 |
RP11-462G12.4 |
|
12629 |
0.19 |
chr6_16421411_16421759 | 0.40 |
ENSG00000265642 |
. |
7169 |
0.31 |
chr21_47519816_47520002 | 0.40 |
COL6A2 |
collagen, type VI, alpha 2 |
1198 |
0.37 |
chr1_39175248_39175457 | 0.40 |
RRAGC |
Ras-related GTP binding C |
150143 |
0.04 |
chr2_47572405_47572655 | 0.40 |
EPCAM |
epithelial cell adhesion molecule |
233 |
0.93 |
chr5_54456050_54456451 | 0.40 |
GPX8 |
glutathione peroxidase 8 (putative) |
252 |
0.86 |
chr1_86046643_86047495 | 0.40 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
625 |
0.71 |
chr9_112887976_112888260 | 0.40 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
337 |
0.93 |
chr18_25755051_25755449 | 0.40 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
2160 |
0.49 |
chr17_3439007_3439187 | 0.40 |
SPATA22 |
spermatogenesis associated 22 |
21951 |
0.11 |
chr20_10585133_10585304 | 0.40 |
JAG1 |
jagged 1 |
57936 |
0.14 |
chr6_14075051_14075202 | 0.40 |
CD83 |
CD83 molecule |
42746 |
0.19 |
chr18_67070028_67070179 | 0.40 |
DOK6 |
docking protein 6 |
1812 |
0.52 |
chr4_4784046_4784388 | 0.40 |
MSX1 |
msh homeobox 1 |
77176 |
0.11 |
chr3_36422437_36422689 | 0.40 |
STAC |
SH3 and cysteine rich domain |
498 |
0.89 |
chr20_57425359_57425924 | 0.40 |
GNAS-AS1 |
GNAS antisense RNA 1 |
292 |
0.85 |
chr3_191067978_191068129 | 0.40 |
UTS2B |
urotensin 2B |
19728 |
0.2 |
chr12_71003154_71004126 | 0.39 |
PTPRB |
protein tyrosine phosphatase, receptor type, B |
16 |
0.99 |
chr18_42258719_42258873 | 0.39 |
SETBP1 |
SET binding protein 1 |
1342 |
0.63 |
chr1_59782411_59782670 | 0.39 |
FGGY |
FGGY carbohydrate kinase domain containing |
6781 |
0.34 |
chr18_32290517_32290846 | 0.39 |
DTNA |
dystrobrevin, alpha |
420 |
0.9 |
chr17_78044749_78045392 | 0.39 |
CCDC40 |
coiled-coil domain containing 40 |
12346 |
0.15 |
chr12_91721216_91721367 | 0.39 |
DCN |
decorin |
144391 |
0.05 |
chr1_147013251_147013702 | 0.39 |
BCL9 |
B-cell CLL/lymphoma 9 |
294 |
0.94 |
chr15_56208944_56209204 | 0.39 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
232 |
0.95 |
chr18_30350998_30351641 | 0.39 |
KLHL14 |
kelch-like family member 14 |
811 |
0.58 |
chr5_158407228_158407437 | 0.39 |
CTD-2363C16.1 |
|
2682 |
0.32 |
chr1_150779096_150779380 | 0.39 |
CTSK |
cathepsin K |
672 |
0.6 |
chr1_7130006_7130266 | 0.39 |
RP11-334N17.1 |
|
55797 |
0.15 |
chr7_47620495_47620884 | 0.39 |
TNS3 |
tensin 3 |
540 |
0.86 |
chrX_34673071_34673254 | 0.39 |
TMEM47 |
transmembrane protein 47 |
2243 |
0.48 |
chr4_77909040_77909436 | 0.39 |
SEPT11 |
septin 11 |
3061 |
0.32 |
chr15_62762265_62762631 | 0.39 |
TLN2 |
talin 2 |
91116 |
0.09 |
chr9_21576531_21576725 | 0.39 |
MIR31HG |
MIR31 host gene (non-protein coding) |
16960 |
0.18 |
chr14_55196902_55197358 | 0.39 |
SAMD4A |
sterile alpha motif domain containing 4A |
24421 |
0.24 |
chr11_104763545_104763789 | 0.39 |
CASP12 |
caspase 12 (gene/pseudogene) |
5474 |
0.23 |
chr12_96183483_96184147 | 0.39 |
NTN4 |
netrin 4 |
89 |
0.96 |
chr13_95753127_95753325 | 0.39 |
ENSG00000252335 |
. |
81737 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.4 | 1.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.4 | 1.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 2.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 1.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.8 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.6 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.6 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.6 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 1.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.7 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.5 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.7 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.4 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.7 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.6 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 1.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 1.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0010667 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.1 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 1.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 1.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.2 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 1.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0060592 | mammary gland formation(GO:0060592) |
0.1 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.3 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.5 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.4 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.2 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.2 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 1.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.6 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.6 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.1 | GO:0072176 | nephric duct development(GO:0072176) |
0.1 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.1 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.1 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.5 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.5 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.2 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.0 | 0.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.8 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 1.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.4 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.4 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 1.2 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 4.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.1 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.1 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.3 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0051938 | L-glutamate import(GO:0051938) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.0 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 1.1 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.2 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.0 | GO:0031650 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.2 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.0 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0072110 | glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.2 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.0 | 0.1 | GO:0045618 | positive regulation of epidermal cell differentiation(GO:0045606) positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.0 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.0 | 0.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.4 | GO:0072163 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:1900076 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.1 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.0 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0060420 | regulation of heart growth(GO:0060420) |
0.0 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.4 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.0 | 0.1 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.1 | GO:0019098 | reproductive behavior(GO:0019098) |
0.0 | 0.0 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.3 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.0 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.0 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.0 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0042551 | neuron maturation(GO:0042551) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.0 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.0 | 0.0 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.0 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.0 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.0 | 0.0 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 0.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.8 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 2.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 2.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.2 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 4.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 11.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 2.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 3.8 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 1.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.0 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.4 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 5.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.0 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 2.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 1.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.9 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 1.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.4 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 1.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.1 | 0.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 3.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 1.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.7 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.9 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 4.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.2 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.4 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.2 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.3 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0000036 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 1.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 2.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.6 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 1.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 3.1 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 4.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.9 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 4.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 5.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.5 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |